Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Chest|April 14, 2004
Viral community-acquired pneumonia in nonimmunocompromised adultsAndrés de Roux, Maria A Marcos, Elisa Garcia, et al.
Antimicrobial Agents and Chemotherapy|February 26, 2004
Early bactericidal activity of moxifloxacin in treatment of pulmonary tuberculosis: a prospective, randomized studyMathias W R Pletz, Andres De Roux, Andreas Roth, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 22, 2002
Changes in fecal flora and comparative multiple-dose pharmacokinetics of ceftibuten, cefpodoxime proxetil and amoxycillin/clavulanateJürg Hamacher, Jörg Luepke, Bruce E. Reidenberg, et al.
The Journal of Antimicrobial Chemotherapy|October 31, 2002
Single- and multiple-dose pharmacokinetics of linezolid and co-amoxiclav in healthy human volunteersOlaf Burkhardt, Klaus Borner, Nicolas von der Höh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 25, 2002
Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosisDavid W Denning, Patricia Ribaud, Noel Milpied, et al.
GMS Infectious Diseases|May 7, 2020
Calculated parenteral initial treatment of bacterial infections: Respiratory infectionsSebastian R Ott, Klaus-Friedrich Bodmann, Béatrice Grabein, et al.
Chest|May 12, 2004
Guidelines for empiric antimicrobial prescribing in community-acquired pneumoniaThomas M File, Javier Garau, Francesco Blasi, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2004
Ertapenem pharmacokinetics and impact on intestinal microflora, in comparison to those of ceftriaxone, after multiple dosing in male and female volunteersMathias W R Pletz, Mareike Rau, Juergen Bulitta, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2008
Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trialAntoni Torres, Javier Garau, Pierre Arvis, et al.
Central European Journal of Public Health|March 6, 2014
Regional advisory board position statement on optimal pneumococcal vaccination in adults. Update to 2011 consensus on adult pneumococcal disease: update on optimal pneumococcal vaccination in adultsEndre Ludwig, Serhat Unal, Miron Bogdan, et al.
Pageof 5